Overcoming 21 CFR compliance challenges – stringent equipment maintenance requirements, overwhelming documentation demands, the need to maintain data integrity. Insights into challenges healthcare organizations face with compliance and how to incorporate new tools and processes for streamlining maintenance processes, reducing compliance burdens, and ensuring the highest standards of safety and efficiency.
How will 2025 rise to the challenge of meeting the demand for personalized healthcare? A perspective on the transformative advancements of 2024—highlighting the impact of AI, robotics, and digital health as they begin to reshape the healthcare landscape.
Wearables are changing the game for health monitoring. From smartwatches and rings to skin patches, glasses, and even bras, companies are in a race to bring the latest innovations to market. But as this trend gains momentum and competition heats up, so do concerns about potential risks like data privacy, cybersecurity vulnerabilities, and the possibility of inaccurate health readings that could critically impact user safety.
The integration of technology and connectivity into healthcare is not only improving patient outcomes but also reshaping the way care is delivered.
Cardiovascular conditions are the leading cause of death. Fortunately, industry leaders are discovering innovative ways to diagnose and treat them. See how mobile apps and AI will change this field in 2025 and beyond.
“Technological progress presents its own challenges, principal among them is that it risks overwhelming healthcare systems with diagnoses of large numbers of patients whose symptoms may be treatable.”
MTI Viewpoints are insights shared by industry relative to healthcare and the advancement of medical technology.
The AI Training Dataset Market size is projected CAGR of 27.7% in the coming years. By 2024, the market had reached an approximate value of USD 2.82 billion and is forecasted to reach USD 9.58 billion by 2029, according to a new report by MarketsandMarkets™.
How can drug delivery devices manage competing priorities – reducing overall carbon footprint without expense to patient and practitioner safety or treatment efficacy. Sustainability strategies must account for commercial and budgetary pressures.
Could MedTech find itself as the collateral damage if an RFK Jr. run HHS “goes wild” with FDA regulation of pharma and processed foods?
